Neurology
Webinar 3 – Epilepsy: Historical Perspectives, Current Practice an Future Directions
This is a series of three 60-minute interactive MOC Section 1 accredited virtual live webinars for Canadian neurologists, epileptologists and other healthcare providers. The goal is to provide education on the evolution of epilepsy care, with a particular focus on the substantial burden of drug-resistant epilepsy (DRE). This webinar series is designed to provide an overview of epilepsy through the lens of time, including historical perspectives, current practice, and the future of epilepsy care. A review of a case example of an individual with DRE will supplement learning and provide practical application of how epilepsy care has progressed.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2025-03-06
Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial number of patients facing drug-resistant epilepsy (DRE). The historical journey from superstition to scientific understanding has greatly influenced the contemporary landscape of epilepsy research and treatment. Dating back to ancient times, epilepsy was often shrouded in misconceptions and attributed to supernatural causes. It was not until the late 19th and early 20th centuries that scientific advancements, such as the discovery of the electrical nature of brain activity, laid the foundation for a more accurate understanding of epilepsy. This newfound knowledge spurred the development of early treatments, including the introduction of antiseizure medications in the mid-20th century. While traditional antiseizure medications (ASMs) have been the cornerstone of epilepsy management for decades, a significant proportion of patients continue to experience seizures despite treatment. Ongoing research and technological advancements are paving the way for more targeted and personalized treatment approaches, offering hope for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Labs Inc.
Faculty
Moderator:
- Esther Bui, MD, FRCPC
Panelist:
- Danielle Andrade, MD, MSc, FRCPC
Learning objectives
After completion of the webinar participants will be better able to:
- Recognize the future implications for redefining drug-resistant epilepsy
- Describe the relationship between precision medicine and epilepsy care
- Describe the potential impact of genetic testing on the future of epilepsy care
- Summarize recent developments of stem cell therapy in the field of epilepsy care
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the ____________. You may claim a maximum of 1.0 hour (credits are automatically calculated).